Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients. 2023

Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal. luismiguelcoelho16@gmail.com.

Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by the newly discovered severe acute respiratory syndrome coronavirus 2. Remdesivir (RDV) and corticosteroids are used mainly in COVID-19 patients with acute respiratory failure. The main objective of the study was to assess the effectiveness of remdesivir with and without corticosteroids in the treatment of COVID-19 patients. We conducted a prospective observational study, including adult patients consecutively hospitalized with confirmed COVID-19 and acute respiratory failure. Patients were divided according to treatment strategy: RDV alone versus RDV with corticosteroids. The primary outcome was the time to recovery in both treatment groups. We included 374 COVID-19 adult patients, 184 were treated with RDV, and 190 were treated with RDV and corticosteroid. Patients in the RDV group had a shorter time to recovery in comparison with patients in the RDV plus corticosteroids group at 28 days after admission [11 vs. 16 days (95% confidence Interval 9.7-12.8; 14.9-17.1; p = .016)]. Patients treated with RDV alone had a shorter length of hospital stay. The use of corticosteroids as adjunctive therapy of RDV was not associated with improvement in mortality of COVID-19 patients.

UI MeSH Term Description Entries
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D000249 Adenosine Monophosphate Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. AMP,Adenylic Acid,2'-AMP,2'-Adenosine Monophosphate,2'-Adenylic Acid,5'-Adenylic Acid,Adenosine 2'-Phosphate,Adenosine 3'-Phosphate,Adenosine 5'-Phosphate,Adenosine Phosphate Dipotassium,Adenosine Phosphate Disodium,Phosphaden,2' Adenosine Monophosphate,2' Adenylic Acid,5' Adenylic Acid,5'-Phosphate, Adenosine,Acid, 2'-Adenylic,Acid, 5'-Adenylic,Adenosine 2' Phosphate,Adenosine 3' Phosphate,Adenosine 5' Phosphate,Dipotassium, Adenosine Phosphate,Disodium, Adenosine Phosphate,Monophosphate, 2'-Adenosine,Phosphate Dipotassium, Adenosine,Phosphate Disodium, Adenosine
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
September 2021, American family physician,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
November 2022, The Journal of infection,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
May 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
April 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
June 2022, Antimicrobial agents and chemotherapy,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
December 2020, European heart journal,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
August 2022, Journal of medical virology,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
March 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
May 2022, The American journal of the medical sciences,
Luís Coelho, and Fatima Falcão, and Pedro Póvoa, and Erica Viegas, and Antonio Pais Martins, and Eduarda Carmo, and Candida Fonseca, and Luis Campos, and Kamal Mansinho, and Inês Carmo, and Joana Soares, and Mariana Solano, and Dina Mendes, and Ana Cláudia Miranda, and Antonio Carvalho, and Ana Mirco, and Helena Farinha, and Isabel Aldir, and José Correia
January 2021, Frontiers in immunology,
Copied contents to your clipboard!